Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL

Abstract Background Blood-borne viral infections, such as HIV and hepatitis C (HCV), are common infections among people who inject drugs (PWID). This study aims to determine the prevalence of HIV and HCV infection among PWID accessing the first legal syringe services program (SSP) in the state of Fl...

Full description

Bibliographic Details
Main Authors: Tyler S. Bartholomew, Jason Onugha, Corinne Bullock, Carolina Scaramutti, Hardik Patel, David W. Forrest, Daniel J. Feaster, Hansel E. Tookes
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Harm Reduction Journal
Online Access:http://link.springer.com/article/10.1186/s12954-020-00385-0
_version_ 1818884211439828992
author Tyler S. Bartholomew
Jason Onugha
Corinne Bullock
Carolina Scaramutti
Hardik Patel
David W. Forrest
Daniel J. Feaster
Hansel E. Tookes
author_facet Tyler S. Bartholomew
Jason Onugha
Corinne Bullock
Carolina Scaramutti
Hardik Patel
David W. Forrest
Daniel J. Feaster
Hansel E. Tookes
author_sort Tyler S. Bartholomew
collection DOAJ
description Abstract Background Blood-borne viral infections, such as HIV and hepatitis C (HCV), are common infections among people who inject drugs (PWID). This study aims to determine the prevalence of HIV and HCV infection among PWID accessing the first legal syringe services program (SSP) in the state of Florida, along with examining baseline correlates of HIV and HCV infection. Methods Baseline behavioral enrollment assessments of 837 participants accessing an SSP for the first time were analyzed. Patients self-reporting or testing HIV or HCV positive at the enrollment visit were included. Socio-demographic, drug use, and injection-related risk behaviors in the last 30 days were compared across groups defined by all combinations of HIV and HCV serostatus. Bivariate and multivariable logistic regression models were used to assess correlates of baseline HCV and HIV infection independently. Results Overall prevalence for HCV and HIV infection were 44.4% and 10.2%, respectively. After adjusting for confounders, the most significant correlates of baseline HCV infection were age (aOR = 1.01), lower education level (aOR = 1.13), currently homeless (aOR = 1.16), injecting more than seven times a day (aOR = 1.14), reusing syringes (aOR = 1.18), and sharing injection equipment (aOR = 1.13). The most significant predictors of baseline HIV infection were age (aOR = 1.01), non-Hispanic Black race (aOR = 1.28), Hispanic ethnicity (aOR = 1.12), gay or bisexual orientation (aOR = 1.22), and methamphetamine injection (aOR = 1.22). In addition, heroin injection (aOR = 0.92) was significantly associated with a lower odds of HIV infection. Discussion/conclusion Baseline behavioral predictors differed between HIV infection and HCV infection among participants accessing syringe services. Understanding the risk factors associated with each infection should be considered when developing additional harm reduction interventions tailored for diverse PWID populations served at SSPs.
first_indexed 2024-12-19T15:45:56Z
format Article
id doaj.art-01bd34f12e0d474e90840494791428d8
institution Directory Open Access Journal
issn 1477-7517
language English
last_indexed 2024-12-19T15:45:56Z
publishDate 2020-06-01
publisher BMC
record_format Article
series Harm Reduction Journal
spelling doaj.art-01bd34f12e0d474e90840494791428d82022-12-21T20:15:20ZengBMCHarm Reduction Journal1477-75172020-06-011711810.1186/s12954-020-00385-0Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FLTyler S. Bartholomew0Jason Onugha1Corinne Bullock2Carolina Scaramutti3Hardik Patel4David W. Forrest5Daniel J. Feaster6Hansel E. Tookes7Department of Public Health Sciences, Miller School of Medicine, University of MiamiDepartment of Public Health Sciences, Miller School of Medicine, University of MiamiDepartment of Public Health Sciences, Miller School of Medicine, University of MiamiDepartment of Public Health Sciences, Miller School of Medicine, University of MiamiDepartment of Public Health Sciences, Miller School of Medicine, University of MiamiDepartment of Anthropology, College of Arts and Sciences, University of MiamiDepartment of Public Health Sciences, Miller School of Medicine, University of MiamiDepartment of Infectious Diseases, Miller School of Medicine, University of MiamiAbstract Background Blood-borne viral infections, such as HIV and hepatitis C (HCV), are common infections among people who inject drugs (PWID). This study aims to determine the prevalence of HIV and HCV infection among PWID accessing the first legal syringe services program (SSP) in the state of Florida, along with examining baseline correlates of HIV and HCV infection. Methods Baseline behavioral enrollment assessments of 837 participants accessing an SSP for the first time were analyzed. Patients self-reporting or testing HIV or HCV positive at the enrollment visit were included. Socio-demographic, drug use, and injection-related risk behaviors in the last 30 days were compared across groups defined by all combinations of HIV and HCV serostatus. Bivariate and multivariable logistic regression models were used to assess correlates of baseline HCV and HIV infection independently. Results Overall prevalence for HCV and HIV infection were 44.4% and 10.2%, respectively. After adjusting for confounders, the most significant correlates of baseline HCV infection were age (aOR = 1.01), lower education level (aOR = 1.13), currently homeless (aOR = 1.16), injecting more than seven times a day (aOR = 1.14), reusing syringes (aOR = 1.18), and sharing injection equipment (aOR = 1.13). The most significant predictors of baseline HIV infection were age (aOR = 1.01), non-Hispanic Black race (aOR = 1.28), Hispanic ethnicity (aOR = 1.12), gay or bisexual orientation (aOR = 1.22), and methamphetamine injection (aOR = 1.22). In addition, heroin injection (aOR = 0.92) was significantly associated with a lower odds of HIV infection. Discussion/conclusion Baseline behavioral predictors differed between HIV infection and HCV infection among participants accessing syringe services. Understanding the risk factors associated with each infection should be considered when developing additional harm reduction interventions tailored for diverse PWID populations served at SSPs.http://link.springer.com/article/10.1186/s12954-020-00385-0
spellingShingle Tyler S. Bartholomew
Jason Onugha
Corinne Bullock
Carolina Scaramutti
Hardik Patel
David W. Forrest
Daniel J. Feaster
Hansel E. Tookes
Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
Harm Reduction Journal
title Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
title_full Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
title_fullStr Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
title_full_unstemmed Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
title_short Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
title_sort baseline prevalence and correlates of hiv and hcv infection among people who inject drugs accessing a syringe services program miami fl
url http://link.springer.com/article/10.1186/s12954-020-00385-0
work_keys_str_mv AT tylersbartholomew baselineprevalenceandcorrelatesofhivandhcvinfectionamongpeoplewhoinjectdrugsaccessingasyringeservicesprogrammiamifl
AT jasononugha baselineprevalenceandcorrelatesofhivandhcvinfectionamongpeoplewhoinjectdrugsaccessingasyringeservicesprogrammiamifl
AT corinnebullock baselineprevalenceandcorrelatesofhivandhcvinfectionamongpeoplewhoinjectdrugsaccessingasyringeservicesprogrammiamifl
AT carolinascaramutti baselineprevalenceandcorrelatesofhivandhcvinfectionamongpeoplewhoinjectdrugsaccessingasyringeservicesprogrammiamifl
AT hardikpatel baselineprevalenceandcorrelatesofhivandhcvinfectionamongpeoplewhoinjectdrugsaccessingasyringeservicesprogrammiamifl
AT davidwforrest baselineprevalenceandcorrelatesofhivandhcvinfectionamongpeoplewhoinjectdrugsaccessingasyringeservicesprogrammiamifl
AT danieljfeaster baselineprevalenceandcorrelatesofhivandhcvinfectionamongpeoplewhoinjectdrugsaccessingasyringeservicesprogrammiamifl
AT hanseletookes baselineprevalenceandcorrelatesofhivandhcvinfectionamongpeoplewhoinjectdrugsaccessingasyringeservicesprogrammiamifl